TRICIDE
Live / Registered — Registered and renewed (as of 22 Dec 2024)
What this means for you
Registered since 17 Aug 2004. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 Aug 2024).
Record
- Serial number
- 78267999
- Registration number
- 2874711
- Mark type
- Word mark
- Filed
- 27 Jun 2003
- Published for opposition
- 25 May 2004
- Registered
- 17 Aug 2004
- Next maintenance due
- 17 Aug 2024
Goods and services
- Class 005 — Pharmaceuticals: Chemical potentiator of antibiotics used to facilitate treatment and prevention of microbial colonization of epithelial and mucosal surfaces for medical use
Owner
- Molecular Therapeutics, Athens, GA, US
- Molecular Therapeutics, Athens, GA, US
- Molecular Therapeutics, Athens, GA, US
Prosecution history
- 22 Dec 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 22 Dec 2024 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 22 Dec 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 22 Dec 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Sept 2024 — TEAS SECTION 8 & 9 RECEIVED
- 17 Aug 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 02 Sept 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 02 Sept 2014 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 02 Sept 2014 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 02 Sept 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Aug 2014 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Aug 2014 — TEAS SECTION 8 & 9 RECEIVED
- 27 Aug 2010 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 27 Aug 2010 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Aug 2010 — TEAS SECTION 8 & 15 RECEIVED